Frequency of phobia among sexual assault victims referred to legal medicine organization in Isfahan province.

Introduction: Phobia is a mental disorder that can occur following rape and pose a serious threat to women's health. The aim of this study was to determine the frequency of paranoia in female victims of rape referred to Isfahan Forensic Medicine Center in 2014. Methods: This descriptive study included 93 women rape victims referred to Isfahan Forensic Medicine Center who were randomly selected. The study tool was the demographic information and mental health questionnaire scl-90. Descriptive statistics and Spearman correlation, independent t test, one-way analysis of variance in SPSS version 17 were used to analyze the data. Results: This study showed that there was a significant positive correlation between rape and phobia (P < 0.001) so that the prevalence of phobia in people who were raped was moderate to high. Also 9.1% (8 people) of mild phobias (scores 1-0), 79.5% (70 people) moderate phobias (scores 1-1) and 11.4% (10 people) phobias in the range Severe (scores 4-3) reported. Of the seven sub-indices in the phobia section, 52.3% (46 people) had very unreasonable fears. Approximately 52.3% (46 people) were afraid of traveling, 46.6% (41 people) were afraid of being alone. Going, 38.6% (34 people) fear of the market, 51.1% (45 people) anxiety, 12.5% (11 people) feeling of alienation, 1.1% (1 person) fear of fainting in total. Conclusion: Due to the increasing number of rapes in women and the recognition of rape as a factor disrupting mental health, strategies and resources should be provided to prevent rape against women and its adverse consequences, including phobia and early diagnosis and treatment of this complication and other complications Be allocated.

The Effect of Dracocephalum Extract on Sleep Quality in Post-Menopausal Women: A Randomized Placebo-Controlled Trial.

Objective: Sleep disturbance is one of the most prevalent problems in post-menopausal females. The current research intended to evaluate the effects of Dracocephalum on sleep disorder in post-menopausal females. Method : The current study is a randomized, double-blind controlled trial, in which 110 post-menopausal women were randomly allocated to Dracocephalum or placebo groups. The intervention group took Dracocephalum capsules containing 250 mg Dracocephalum extract twice daily for one month. While, the placebo group took the same capsule containing 250 mg of starch twice daily for one month. Pittsburgh Sleep Quality Index was completed by the participants of both groups before and after the treatment and the data obtained were analyzed with Chi-square, paired and independent t-test in SPSS (version 20). Results: The mean score of sleep quality before and after the treatment was 12.69 ± 3.98 and 8.58 ± 1.97 in the treatment group, respectively. Also, the score of sleep quality in the placebo group was 13.48 ± 2.60 and 11.21 ± 2.74 at the beginning and end of the research, respectively. The symptoms of sleep disorder in the intervention group significantly improved after the treatment (P < 0.001), while this was not the case with the placebo group (P = 0.155). Besides, there was a significant difference between the two groups in the mean score of sleep quality after the treatment (P = 0.012). Conclusion: Dracocephalum extracts are effective in reducing symptoms of sleep disorders in post-menopausal women.

Effect of Hydroalcoholic Extracts of Capsella Bursa-Pastoris on Heavy Menstrual Bleeding: A Randomized Clinical Trial.

OBJECTIVES: Heavy menstrual bleeding (HMB) is one of the leading causes of low quality of life and iron deficiency anemia in women. This study aimed to determine the effect of hydroalcoholic extracts of Capsella bursa-pastoris on HMB. DESIGN: This study is a triple-blinded, randomized clinical trial. SETTING: The study was conducted in gynecology clinics affiliated to Shahid Beheshti University of Medical Sciences, Tehran, Iran. SUBJECTS: Our patients affected to a complaint of HMB. After obtaining a complete medical history of the women and filling out the demographic forms, the participants were assigned randomly into the experimental (n = 42) and control groups (n = 42). INTERVENTION: The eligible participants were given a pictorial blood loss assessment chart (PBLAC) to confirm HMB during the menstrual cycle. The experimental group received two capsules of mefenamic acid (500 mg) every 8 h and two Capsella bursa-pastoris capsules every 12 h. The intervention started from the first day of menstruation to the end of this period up to 7 days for two consecutive cycles. In the control group, the patients received mefenamic acid and placebo instead of Capsella bursa-pastoris capsules. OUTCOME MEASUREMENTS: The PBLAC score and number of bleeding days, incidence of any possible problems, as well as participant satisfaction were measured. The data were analyzed using t-test, Chi-square, repeated-measures ANOVA, and ANCOVA tests in PASW Statistics ver. 18. RESULTS: After the intervention, there was observed significant decrease in the amount of menstrual bleeding in both groups. However, the mean decrease in the amount of bleeding was significantly more in the Capsella bursa-pastoris group (p < 0/001). CONCLUSION: Compared with control group, hydroalcoholic extracts of Capsella bursa-pastoris capsule appeared to be effective in reducing menstrual bleeding in this study. Further research regarding the efficacy and safety of Capsella bursa-pastoris is required.